Exagen appoints Ana Hooker to board of directors; she is SVP Operations at Exact Sciences

EXAGEN INC.

Board increased from 8 to 9 members; appointment effective July 29, 2021.
Hooker receives option to purchase 15,000 shares, vesting over 3 years monthly, plus cash compensation per non-employee director plan.
Hooker is SVP Operations at Exact Sciences since 2015; previously 15 years at ARUP Laboratories.
Board determined Hooker is independent under Nasdaq listing standards.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ana Hooker

Director

XGN · EXAGEN INC.

Effective: 2021-07-29
Filed: July 30, 2021, 7:59 PM ET

the Board approved an increase in its authorized size from eight members to nine members and appointed Ana Hooker to fill the vacancy created by such increase and serve as a Class II director, with an initial term expiring at the Company's 2024 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Ana Hooker was appointed as Director at EXAGEN INC..

Action: appointed
Role: Director

Exact text from the filing

the Board approved an increase in its authorized size from eight members to nine members and appointed Ana Hooker to fill the vacancy created by such increase and serve as a Class II director, with an initial term expiring at the Company's 2024 annual meeting of stockholders.

View on SEC.gov

EXAGEN INC. filing history →

Source: SEC EDGAR

accession 0001274737-21-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.